Carl Zeiss Meditec (ETR:AFX) Trading Down 5.7% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFXGet Free Report)’s share price was down 5.7% during trading on Friday . The company traded as low as €50.85 ($53.53) and last traded at €50.95 ($53.63). Approximately 489,838 shares traded hands during mid-day trading, an increase of 419% from the average daily volume of 94,405 shares. The stock had previously closed at €54.05 ($56.89).

Carl Zeiss Meditec Stock Performance

The business has a 50-day simple moving average of €60.07 and a 200 day simple moving average of €64.64. The company has a debt-to-equity ratio of 6.74, a current ratio of 3.51 and a quick ratio of 2.47. The firm has a market cap of $4.56 billion, a PE ratio of 22.35, a PEG ratio of 2.83 and a beta of 0.98.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Articles

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.